Evidence map›Paper›PMID 41206110›Full record

ArticleBriefings in bioinformatics2025

MOFormer: navigating the antimicrobial peptide design space with Pareto-based multi-objective transformer.

Li Wang, Xiangzheng Fu, Jiahao Yang, Xinyi Zhang, Xiucai Ye, Tetsuya Sakurai, Xiangxiang Zeng, Yiping Liu

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Li WangDepartment of Computer Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
Xiangzheng FuSchool of Chinese Medicine, Hong Kong Baptist University, 7 Baptist University Road, Kowloon Tong, Kowloon, Hong Kong 999077, China.
Jiahao YangCollege of Computer Science and Electronic Engineering, Hunan University, Lushan South Road, Yuelu District, Changsha, Hunan 410082, China.
Xinyi ZhangCollege of Computer Science and Electronic Engineering, Hunan University, Lushan South Road, Yuelu District, Changsha, Hunan 410082, China.
Xiucai YeDepartment of Computer Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
Tetsuya SakuraiDepartment of Computer Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
Xiangxiang ZengCollege of Computer Science and Electronic Engineering, Hunan University, Lushan South Road, Yuelu District, Changsha, Hunan 410082, China.
Yiping LiuCollege of Computer Science and Electronic Engineering, Hunan University, Lushan South Road, Yuelu District, Changsha, Hunan 410082, China.

Funding

Hunan Provincial Natural Science Foundation of China 2022JJ40090Hunan Provincial Natural Science Foundation of China 2024JJ4015JSPS KAKENHI JP22K12144JSPS KAKENHI JP23H03411JST JPMJPF2017National Natural Science Foundation of China 62106073National Natural Science Foundation of China 62122025National Natural Science Foundation of China 62250028National Natural Science Foundation of China 62372158National Natural Science Foundation of China 62472152National Natural Science Foundation of China 62522110National Natural Science Foundation of China 662002111National Natural Science Foundation of China U22A2037
6 · The paper itself

Abstract

Antimicrobial peptide (AMP) design through deep learning holds the potential to revolutionize antibiotic development. Despite recent progress in AMP generation, designing peptide antibiotics with multiple optimal properties remains a significant challenge. We present MOFormer, an advanced multi-objective AMP design pipeline capable of optimizing multiple AMP properties simultaneously. By leveraging a conditional Transformer, the model refines the AMP sequence-property landscape for efficient multi-objective generation. It also incorporates regularization techniques to maintain a highly structured space, enabling the sampling of precise and desirable candidates. Comparative analyses reveal that MOFormer achieves the optimal hypervolume in the multi-objective space, surpassing advanced methods in simultaneously maximizing antimicrobial activity (minimum inhibitory concentration) and minimizing hemolysis and toxicity, thereby yielding the most promising and desirable set of candidate peptides. When extended to a tri-objective scenario, MOFormer continues to exhibit remarkable optimization performance. Finally, we execute a hierarchical and rapid ranking of generated candidates based on Pareto fronts. We conducted a comprehensive validation of the physicochemical properties and target attributes of the candidates, while AlphaFold structure predictions revealed notably reliable predicted local distance difference test scores ranging from 70% to 87%. Our findings suggest that MOFormer holds potential to accelerate the discovery of efficacious peptide antibiotics by optimizing multi-objective trade-offs.

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesDrug DesignAlgorithmsDeep LearningMicrobial Sensitivity TestsAnti-Bacterial AgentsAntimicrobial Peptidesantimicrobial peptidedeep generative networksmulti-objective trade-offPareto frontTransformer

Identifiers

PMID41206110
PMCPMC12596111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.